We use cookies to customise content for your subscription and for analytics. If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
The Commission has declined to enter a consent order, and instead terminated on the basis of a settlement agreement, Inv. No. 337-TA-568, Certain Products and Pharmaceutical Compositions Containing Recombinant Human Erythropoetin
ALJ Rogers denied a Motion for Presumption of Infringement Under 35 U.S.C. 295 filed by Eli Lilly & Company (“Lilly”) in Inv. No. 337-TA-766, Certain Gemcitabine and Products Containing the Same
